| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 3.913 | 7.897 | 4.919 | 7.280 | 12.584 | 12.080 | 18.482 | 17.260 |
| Total Income - EUR | - | 0 | 3.916 | 7.897 | 4.923 | 7.281 | 12.584 | 12.080 | 18.482 | 17.260 |
| Total Expenses - EUR | - | 192 | 784 | 614 | 5.797 | 9.356 | 8.542 | 7.111 | 9.548 | 12.454 |
| Gross Profit/Loss - EUR | - | -192 | 3.132 | 7.283 | -873 | -2.075 | 4.043 | 4.969 | 8.935 | 4.806 |
| Net Profit/Loss - EUR | - | -192 | 3.015 | 7.046 | -1.021 | -2.279 | 3.672 | 4.614 | 7.050 | 3.752 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Ernestinamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 96 | 95 | 0 | 22.164 | 15.813 | 10.942 | 5.241 | 401 | 561 |
| Current Assets | - | 68 | 3.239 | 9.917 | 4.841 | 6.930 | 2.363 | 3.032 | 7.984 | 10.457 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 52 | 0 | 0 |
| Receivables | - | 0 | 585 | 295 | 110 | 483 | 123 | 45 | 628 | 121 |
| Cash | - | 68 | 2.654 | 9.622 | 4.731 | 6.447 | 2.240 | 2.936 | 7.356 | 10.336 |
| Shareholders Funds | - | -148 | 2.869 | 9.863 | 8.650 | 6.208 | 9.743 | 7.878 | 7.212 | 10.924 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 312 | 464 | 55 | 18.354 | 16.535 | 3.562 | 395 | 1.173 | 94 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ernestinamed Srl